| NCT Number | NCT07478016 |
| Lead Sponsor | Thomas Jefferson University |
| Conditions | Breast Cancer, Ductal Carcinoma In Situ |
| Enrollment | 200 participants |
| Start Date | 2022-12-21 |
| Primary Completion | 2027-12-31 (estimated) |
| Study Completion | 2028-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-03-17 |